The Hospice Advanced Dementia Symptom Management and Quality of Life Trial (HAS-QOL)
Status
Conditions
Treatments
Details and patient eligibility
About
Alzheimer's Disease and Related Disorders (dementia) are a group of serious life limiting illness that cause significant challenges to our public health system, with significant illness burden for both the person with dementia and the caregiver. At the end of life, over 230,000 persons with dementia annually are cared for in hospice, yet hospice agencies are ill prepared to care for this population and often resort to inappropriate pharmacologic measures such as antipsychotics that reduce quality of life rather than improve it. This study will therefore through its two phases refine and then implement, using a pragmatic stepped wedge trial design, the Dementia Symptom Management at Home Program Hospice Edition, with the goal improving quality of care for the person with dementia and their caregiver, reducing antipsychotic use, and increasing bereaved caregiver satisfaction in the hospice setting.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Must have dementia as primary diagnosis for admission to hospice
- Must be newly admitted to a participating hospice
- Must be 50 years or older
Clinicians:
- Must be a skilled clinician or home health aide who provides care through an eligible home health agency
- Must be 18 years or older
Exclusion criteria
Persons with Dementia:
- None
Clinicians:
- None
Trial design
Primary purpose
Allocation
Interventional model
Masking
83 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal